ACCUMED INTERNATIONAL INC
10-Q, EX-27, 2000-11-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: ACCUMED INTERNATIONAL INC, 10-Q, 2000-11-14
Next: NOVADIGM INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                             168
<SECURITIES>                                       183
<RECEIVABLES>                                        8
<ALLOWANCES>                                         0
<INVENTORY>                                        687
<CURRENT-ASSETS>                                 1,240
<PP&E>                                           2,066
<DEPRECIATION>                                   1,593
<TOTAL-ASSETS>                                   6,238
<CURRENT-LIABILITIES>                            1,606
<BONDS>                                            630
                               57
                                          0
<COMMON>                                         2,762
<OTHER-SE>                                         744
<TOTAL-LIABILITY-AND-EQUITY>                     6,238
<SALES>                                            229
<TOTAL-REVENUES>                                   356
<CGS>                                               81
<TOTAL-COSTS>                                       81
<OTHER-EXPENSES>                                 3,003
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  23
<INCOME-PRETAX>                                (2,158)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (2,158)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,158)
<EPS-BASIC>                                     (0.38)
<EPS-DILUTED>                                   (0.38)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission